Annual ROE
-38.37%
-13.88%-56.68%
December 31, 2024
Summary
- As of March 12, 2025, AVIR annual return on equity is -38.37%, with the most recent change of -13.88% (-56.68%) on December 31, 2024.
- During the last 3 years, AVIR annual ROE has fallen by -57.64% (-299.12%).
- AVIR annual ROE is now -235.54% below its all-time high of 28.31%, reached on December 31, 2019.
Performance
AVIR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-35.86%
-0.96%-2.75%
December 31, 2024
Summary
- As of March 12, 2025, AVIR quarterly return on equity is -35.86%, with the most recent change of -0.96% (-2.75%) on December 31, 2024.
- Over the past year, AVIR quarterly ROE has dropped by -12.79% (-55.44%).
- AVIR quarterly ROE is now -104.44% below its all-time high of 807.89%, reached on September 30, 2020.
Performance
AVIR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AVIR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.7% | -55.4% |
| 3 y3 years | -299.1% | -66.9% |
| 5 y5 years | -235.5% | -66.9% |
AVIR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -299.1% | at low | -278.9% | at low |
| 5 y | 5-year | -235.5% | at low | -104.4% | +49.2% |
| alltime | all time | -235.5% | at low | -104.4% | +49.2% |
Atea Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -38.37%(+56.7%) | -35.86%(+2.8%) |
| Sep 2024 | - | -34.90%(+5.0%) |
| Jun 2024 | - | -33.24%(+13.9%) |
| Mar 2024 | - | -29.18%(+26.5%) |
| Dec 2023 | -24.49%(+35.4%) | -23.07%(+7.4%) |
| Sep 2023 | - | -21.49%(+27.8%) |
| Jun 2023 | - | -16.82%(-0.6%) |
| Mar 2023 | - | -16.93%(-3.4%) |
| Dec 2022 | -18.09% | -17.53%(-433.3%) |
| Sep 2022 | - | 5.26%(+122.9%) |
| Jun 2022 | - | 2.36%(-68.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 7.54%(-62.4%) |
| Dec 2021 | 19.27%(-539.0%) | 20.04%(+263.0%) |
| Sep 2021 | - | 5.52%(-35.3%) |
| Jun 2021 | - | 8.53%(+5.0%) |
| Mar 2021 | - | 8.12%(-244.5%) |
| Dec 2020 | -4.39%(-115.5%) | -5.62%(-100.7%) |
| Sep 2020 | - | 807.89%(-1243.7%) |
| Jun 2020 | - | -70.64%(-385.3%) |
| Mar 2020 | - | 24.76%(+48.1%) |
| Dec 2019 | 28.31%(+12.9%) | 16.72% |
| Dec 2018 | 25.07% | - |
FAQ
- What is Atea Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual ROE year-on-year change?
- What is Atea Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly ROE year-on-year change?
What is Atea Pharmaceuticals annual return on equity?
The current annual ROE of AVIR is -38.37%
What is the all time high annual ROE for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual return on equity is 28.31%
What is Atea Pharmaceuticals annual ROE year-on-year change?
Over the past year, AVIR annual return on equity has changed by -13.88% (-56.68%)
What is Atea Pharmaceuticals quarterly return on equity?
The current quarterly ROE of AVIR is -35.86%
What is the all time high quarterly ROE for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly return on equity is 807.89%
What is Atea Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, AVIR quarterly return on equity has changed by -12.79% (-55.44%)